Clinical trials: Cholera Vaccination Reaction, open to volunteers
Cholera Vaccination Reaction
Safety and Immunogenicity Study of the DuoChol Oral Cholera Vaccine in Healthy Participants
The goal of this phase I, open-label, randomized, active-controlled Trial is to evaluate the safety and immunogenicity of the DuoChol Oral Cholera Vaccine in 18 to 45 years old healthy participants in Sweden.
- Trial name
- DuoChol (NCT07270796)
- Testing
- DuoChol, Dukoral®
- Where
- Sweden
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- International Vaccine Institute
Cholera Vaccination Reaction
Phase 1b Ascending Dose Study of PanChol in Healthy Volunteers
Cholera is a serious diarrheal disease that can be fatal within hours of onset. The current available cholera vaccines to prevent the disease are not very effective.
- Trial name
- PanChol (NCT07107516)
- Testing
- PanChol
- Where
- Zambia
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Centre for Infectious Disease Research in Zambia